40+ and Feeling It? Dr. Nathan Starke Reveals the Best Peptides For Men

There’s a version of your 40s that doesn’t announce itself loudly. You’re not sick. You’re not in pain. You just notice, gradually, that things are harder than they used to be. The workouts take longer to recover from. The weight around your midsection is more stubborn. Sleep is lighter. The mental sharpness you used to rely on has gotten a little blurry around the edges.

Most men chalk this up to aging and stop there. Dr. Nathan Starke, a fellowship-trained urologist, andrologist, and founder of Starke Medical Group in Houston, designed his private concierge with this type of patient in mind.

“He’s frustrated because every doctor has told him he’s normal, sent him home,” Dr. Starke says, describing the patient who shaped the original vision for his concierge practice. “That man is my patient.”

For men in this position, peptide therapy has become an increasingly relevant part of the conversation—and a central part of what Starke Medical offers. Here’s what Dr. Starke wants men over 40 to understand about using peptides to prove that life can always get better with age.

Why Turning 40 Changes Things for Men’s Health

The biological shift men experience in their 40s isn’t dramatic — it’s slow enough to be easy to miss until it compounds. Growth hormone production, which peaks in your 20s, declines significantly by middle age. Your body’s ability to repair muscle tissue, maintain lean mass, and recover from physical stress becomes measurably less efficient. Sleep quality, which is both a cause and an effect of growth hormone release, tends to deteriorate alongside it.

Testosterone, often treated as the only variable, is often a big part of the picture but certainly not all of it for every man. Hormonal health is a complex system. When multiple variables shift at once, the combined effect can feel like a lot more than the sum of its parts.

Dr. Nathan Starke’s background in andrology — the specialty focused on men’s hormonal and reproductive health — means he approaches these cases by looking at the whole picture rather than treating each symptom in isolation.

“When someone comes to me with erectile dysfunction, I’m not just writing a prescription and calling it done. I’m thinking about vascular health, hormone status, neurological issues, and even psychology — the full patient picture.”

Best Peptides For Men Over 40

Peptide therapy for men over 40 is largely built around one goal: supporting the body’s hormonal systems back toward more youthful function, without simply flooding the system with synthetic hormones.

That distinction matters. Directly injecting growth hormone can suppress the body’s own production and comes with significant side effects. Growth hormone secretagogue peptides work differently. They signal the pituitary gland to release more of your own growth hormone through the body’s natural pulsatile rhythm — the way it did when you were younger.

CJC-1295 and Ipamorelin

The most commonly used combination for growth hormone support. CJC-1295 mimics growth hormone-releasing hormone; Ipamorelin works through a separate receptor pathway. Together, they produce a synergistic growth hormone pulse. Men who use this combination under medical supervision often report better body composition, improved sleep quality, faster exercise recovery, and more consistent energy.

While several studies have shown that these compounds are safe and effective, they are not FDA-approved for anti-aging or performance purposes in healthy adults. They’re prescribed off-label. Dr. Starke is explicit about this distinction: “Even though I believe in the potential of these therapies, there’s a lot we don’t know. It’s important to say that out loud.”

Tesamorelin

An FDA-approved growth hormone-releasing hormone analog with randomized controlled trial data supporting its ability to reduce visceral abdominal fat. For men carrying stubborn midsection weight despite reasonable diet and exercise habits, it’s one of the more evidence-backed peptide tools available.

PT-141 (Bremelanotide)

For men whose concerns include changes in sexual function — extremely common in this age group — PT-141 offers something the standard ED drugs don’t. It acts in the brain rather than on blood flow, working on the brain’s arousal circuitry directly. FDA-approved for hypoactive sexual desire disorder; physicians prescribe it for men dealing with both physical and psychological components of sexual dysfunction.

Sermorelin

Sermorelin is an older growth hormone secretagogue with a longer safety track record than newer compounds like CJC-1295 or Ipamorelin. Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — it signals the pituitary gland to produce and release more of your own growth hormone, rather than introducing synthetic GH directly.

It’s been used clinically for growth hormone deficiency since the 1990s, which means physicians have a much longer window of real-world safety and dosing data to draw from. For men who are new to peptide therapy, or who want the metabolic and recovery benefits of GH support without stepping into less-charted territory, it’s often the natural starting point. Results tend to be more gradual than with newer secretagogue combinations, but for men playing a long game with their health rather than chasing rapid changes, that measured pace is often exactly the point.

Semaglutide

Semaglutide — the active compound in Ozempic and Wegovy — is best known for weight loss, but its benefits for men over 40 run deeper than the number on the scale. As men age, visceral fat accumulates around the midsection and drives a cascade of problems: chronic low-grade inflammation, insulin resistance, declining testosterone, and sluggish energy that no amount of sleep seems to fix. Semaglutide addresses that root metabolic dysfunction directly.

By regulating blood sugar, reducing appetite, and improving insulin sensitivity, it helps the body shift away from fat storage and toward the kind of metabolic efficiency that supports real energy. Dr. Nathan Starke’s own research has shown that as visceral fat drops, testosterone often responds — the two are closely linked, since excess body fat accelerates the conversion of testosterone to estrogen.

Tirzepatide

Tirzepatide — sold as Mounjaro for type 2 diabetes and Zepbound for obesity — takes the semaglutide approach one meaningful step further. Where semaglutide acts on a single receptor, tirzepatide is a dual agonist: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. That second pathway isn’t just incremental — GIP plays a distinct role in fat metabolism and insulin regulation, and the combination produces results semaglutide can’t fully match. Clinical trials have shown average weight loss of up to 22.5% of body weight, with tirzepatide outperforming semaglutide in direct comparisons. For men in their 40s whose central struggle is visceral fat that hasn’t responded to diet, exercise, or even semaglutide, the difference is clinically meaningful.

The hormonal implications deserve separate attention. Research presented at ENDO 2025 found that tirzepatide was associated with improved testosterone levels in men with obesity and metabolic hypogonadism — the condition where accumulated body fat suppresses testosterone rather than any primary hormonal failure. Tirzepatide has also received FDA approval for obstructive sleep apnea, which matters for men’s health specifically: untreated sleep apnea quietly destroys both testosterone production and recovery quality, and it goes undiagnosed in a significant portion of the men who have it. For a patient carrying overlapping concerns — visceral fat, declining testosterone, and poor sleep — tirzepatide can address all three entry points from a single intervention.

Coming Soon: Retatrutide

If tirzepatide moved the ceiling on what metabolic pharmacology can achieve, retatrutide appears to be threatening to raise it entirely. Eli Lilly’s investigational triple agonist activates three metabolic receptors simultaneously — GLP-1, GIP, and glucagon — a combination the longevity and wellness space has been watching closely since Phase 2 data first appeared. Phase 3 results from the TRIUMPH-1 trial confirmed what earlier signals suggested: participants on the 12 mg dose lost an average of 28.3% of their body weight at 80 weeks — roughly 70 pounds — with 45% of participants achieving 30% or greater total weight loss. For context, those numbers approach bariatric surgery outcomes without the procedure.

Retatrutide is not yet FDA-approved and won’t be available through legitimate medical channels until that process completes, with additional trial data expected throughout 2026. But the wellness space is already buzzing around it, and that interest isn’t entirely misplaced. The triple-agonist mechanism addresses metabolic dysfunction at a depth that first-generation GLP-1 compounds couldn’t reach — and for men whose visceral fat, insulin resistance, and declining testosterone have proven resistant to everything else, it represents a genuinely new category of intervention. Dr. Starke is tracking the Phase 3 data closely. When retatrutide becomes available through responsible medical practice, it will be a natural extension of the toolkit Starke Medical is already building.

Peptide Therapy for Men’s Health: How to Beat the Mid-40s Slump

For Nathan Starke, offering peptide therapy wasn’t a decision to follow a trend. It was a decision about how to serve this specific patient — the high-performing man in his 40s who has been told he’s fine while not feeling fine — in a way the traditional system hadn’t.

“Patients of Starke Medical will be able to access nearly everything they’ve read about or are curious about,” he says. “But the difference is it won’t be them doing it by their lonesome. What I offer is a structural alternative — proper evaluation, peptide compounds sourced from reputable pharmacies, and regular follow-up with labs and real conversations about how the patient is actually responding.”

The concern he returns to consistently is the alternative: men sourcing peptides online from unregulated vendors, with no baseline bloodwork, no monitoring, and no one to call when something feels off. “The goal is to take something that often happens in the shadows and make it as safe and evidence-informed as possible.”

That means a membership structure designed to make the ongoing relationship easy — direct access to Dr. Starke by call or text, house calls in Houston, telemedicine across Texas, and the continuity that episodic care never provides.

Getting the fundamentals right comes first. Sleep, exercise, diet, and a clear understanding of your baseline labs are the foundation everything else builds on. But for men who have those fundamentals reasonably in place and are still feeling the gap between where they are and where they want to be, this conversation is worth having — and now there’s a practice built specifically to have it.

Stay updated, free articles. Join our Telegram channel

Jun 24, 2026 | Posted by in GENERAL SURGERY | Comments Off on 40+ and Feeling It? Dr. Nathan Starke Reveals the Best Peptides For Men

Full access? Get Clinical Tree

Get Clinical Tree app for offline access